- Investing Ideas
- /
- Norwegian Pharmaceuticals & Biotech Potentially Undervalued Companies
Norwegian Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
5
Companies with a Value score of at least 3, ordered by Value score
5 companies
Navamedic
Market Cap: NOK 379.7m
A pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally.
NAVA
NOK 21.50
7D
-1.4%
1Y
-28.6%
Norda
Market Cap: NOK 415.7m
A biotechnology company, engages in the cancer diagnostic activities.
NORD
NOK 81.00
7D
0%
1Y
95.2%
Vistin Pharma
Market Cap: NOK 1.0b
Through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) worldwide.
VISTN
NOK 23.10
7D
-1.3%
1Y
-17.2%
Photocure
Market Cap: NOK 1.5b
Engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products.
PHO
NOK 57.40
7D
-4.0%
1Y
8.7%
Arctic Bioscience
Market Cap: NOK 100.7m
A clinical-stage biotechnology company, engages in developing and commercializing pharmaceutical and nutraceutical ingredients based on bioactive marine compounds in Norway, the United States, Europe, and Asia Pacific.
ABS
NOK 3.75
7D
-5.1%
1Y
-72.6%